NCT05318976Phase 2Completed

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

Study sponsor: Inmune Bio, Inc. · INMB

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-05-12Actual
Enrollment · participants207Actual
Source updated2026-06-29Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Actual enrollment decreased by 1 participants

Before: 208 participants (actual). After: 207 participants (actual).

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview